Inmune Bio (INMB) Revenue (2021 - 2025)
Inmune Bio (INMB) posted Revenue of $50000.0 for Q1 2025, up 257.14% sequentially from $14000.0 in Q1 2024, and up 257.14% YoY from $14000.0 in Q1 2024.
Inmune Bio (INMB) Revenue (2021 - 2025) Analysis & Trends
Inmune Bio has reported Revenue for 5 years, with the latest figure at $50000.0 in Q1 2025.
- Quarterly Revenue rose 257.14% year-over-year to $50000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $50000.0 (up 257.14% YoY) and the FY2025 annual result came in at $50000.0, up 257.14% from the prior year.
- Revenue climbed to $50000.0 in Q1 2025 per INMB's latest filing, from $14000.0 in the prior quarter.
- Over five years, Revenue peaked at $163000.0 in Q4 2021 and troughed at $4000.0 in Q1 2021.
- A 5-year average of $59538.5 and a median of $43000.0 in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue jumped 3975.0% in 2022, then plunged 76.69% in 2023.
- Over 5 years, Revenue stood at $163000.0 in 2021, then tumbled by 40.49% to $97000.0 in 2022, then slumped by 71.13% to $28000.0 in 2023, then slumped by 50.0% to $14000.0 in 2024, then soared by 257.14% to $50000.0 in 2025.
- According to Business Quant data, Revenue over the past three periods registered $50000.0, $14000.0, and $28000.0 for Q1 2025, Q1 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 674.14 Mn |
| 10 | Inmune Bio | 61.59 Mn | 43.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 50,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 46,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 97,000.00 |
| Sep 30, 2022 | 98,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 163,000.00 |
| Dec 31, 2021 | 163,000.00 |
| Sep 30, 2021 | 14,000.00 |
| Mar 31, 2021 | 4,000.00 |